Peak Bio, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Peak Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2022 to Q3 2024.
  • Peak Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $0.000, a 100% decline year-over-year.
  • Peak Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was -$69.3K, a 114% decline year-over-year.
  • Peak Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $275K, a 50.8% decline from 2022.
  • Peak Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $560K, a 11353% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$69.3K $0 -$76.8K -100% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $7.48K $0 -$133K -100% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-23
Q1 2024 $141K $30.5K -$134K -81.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-23
Q4 2023 $275K -$99.8K -$228K -178% Oct 1, 2023 Dec 31, 2023 10-K 2024-08-06
Q3 2023 $503K $76.8K -$81.8K -51.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $585K $133K -$32.3K -19.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-23
Q1 2023 $617K $165K +$57K +52.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-23
Q4 2022 $560K $128K Oct 1, 2022 Dec 31, 2022 10-K 2024-08-06
Q3 2022 $159K Jul 1, 2022 Sep 30, 2022 10-Q 2024-06-25
Q2 2022 $166K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 $108K Jan 1, 2022 Mar 31, 2022 10-Q 2023-07-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.